CEBPA

Results: 4



#Item
1LETTER  doi:nature09999 A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia

LETTER doi:nature09999 A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia

Add to Reading List

Source URL: michorlab.dfci.harvard.edu

Language: English - Date: 2014-08-06 11:15:16
2Table 13.1  Classification of acute myeloid leukaemia (AML) according to the WHO classification[removed]modified). Acute myeloid leukaemia with recurrent genetic abnormalities AML with t(8;21)(q22;q22); RUNX1-RUNX1T1

Table 13.1  Classification of acute myeloid leukaemia (AML) according to the WHO classification[removed]modified). Acute myeloid leukaemia with recurrent genetic abnormalities AML with t(8;21)(q22;q22); RUNX1-RUNX1T1

Add to Reading List

Source URL: www.essentialhaematology6.com

Language: English - Date: 2011-02-25 06:19:27
3Beneficiary Full Name: ___________________________________________	 Sponsor’s SSN: ______-_____-_______ Date of Birth: ____________________________________ Beneficiary State of Residence:  _______________  Dear Provide

Beneficiary Full Name: ___________________________________________ Sponsor’s SSN: ______-_____-_______ Date of Birth: ____________________________________ Beneficiary State of Residence: _______________ Dear Provide

Add to Reading List

Source URL: www.hnfs.com

Language: English - Date: 2015-01-02 17:18:38
4Wilms’ Tumour gene (WT1) as a potential MRD marker in AML David Grimwade  Standardised leukaemia-specific RT-qPCR assays for

Wilms’ Tumour gene (WT1) as a potential MRD marker in AML David Grimwade Standardised leukaemia-specific RT-qPCR assays for

Add to Reading List

Source URL: www.fda.gov

Language: English